IL33 and colorectal carcinoma: Mechanistically, IL-33 promotes epithelial mesenchymal transition (EMT) characterised by decreased E-cadherin and increased vimentin and N-cadherin expression in HT29 human CRC cells, and induced migration in a wound healing assay in vitro.